ID   TNNI3_HUMAN             Reviewed;         210 AA.
AC   P19429;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   07-APR-2021, entry version 206.
DE   RecName: Full=Troponin I, cardiac muscle;
DE   AltName: Full=Cardiac troponin I;
GN   Name=TNNI3; Synonyms=TNNC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart muscle;
RX   PubMed=2226790; DOI=10.1016/0014-5793(90)81234-f;
RA   Vallins W.J., Brand N.J., Dabhade N., Butler-Browne G., Yacoub M.H.,
RA   Barton P.J.R.;
RT   "Molecular cloning of human cardiac troponin I using polymerase chain
RT   reaction.";
RL   FEBS Lett. 270:57-61(1990).
RN   [2]
RP   SEQUENCE REVISION TO 85, AND NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8406024; DOI=10.1016/0378-1119(93)90308-p;
RA   Armour K.L., Harris W.J., Tempest P.R.;
RT   "Cloning and expression in Escherichia coli of the cDNA encoding human
RT   cardiac troponin I.";
RL   Gene 131:287-292(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1934363; DOI=10.1161/01.res.69.5.1409;
RA   Hunkeler N.M., Kullman J., Murphy A.M.;
RT   "Troponin I isoform expression in human heart.";
RL   Circ. Res. 69:1409-1414(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8661099; DOI=10.1006/geno.1996.0317;
RA   Bhavsar P.K., Brand N.J., Yacoub M.H., Barton P.J.R.;
RT   "Isolation and characterization of the human cardiac troponin I gene
RT   (TNNI3).";
RL   Genomics 35:11-23(1996).
RN   [5]
RP   PROTEIN SEQUENCE OF 11-36, ACETYLATION AT ALA-2, AND PHOSPHORYLATION AT
RP   SER-23 AND SER-24.
RX   PubMed=2226863; DOI=10.1016/0014-5793(90)81046-q;
RA   Mittmann K., Jaquet K., Heilmeyer L.M.G. Jr.;
RT   "A common motif of two adjacent phosphoserines in bovine, rabbit and human
RT   cardiac troponin I.";
RL   FEBS Lett. 273:41-45(1990).
RN   [6]
RP   PHOSPHORYLATION AT SER-23 AND SER-24.
RX   PubMed=9346285; DOI=10.1111/j.1432-1033.1997.00329.x;
RA   Keane N.E., Quirk P.G., Gao Y., Patchell V.B., Perry S.V., Levine B.A.;
RT   "The ordered phosphorylation of cardiac troponin I by the cAMP-dependent
RT   protein kinase -- structural consequences and functional implications.";
RL   Eur. J. Biochem. 248:329-337(1997).
RN   [7]
RP   PHOSPHORYLATION AT SER-150 BY PAK3.
RX   PubMed=12242269; DOI=10.1161/01.res.0000035246.27856.53;
RA   Buscemi N., Foster D.B., Neverova I., Van Eyk J.E.;
RT   "p21-activated kinase increases the calcium sensitivity of rat triton-
RT   skinned cardiac muscle fiber bundles via a mechanism potentially involving
RT   novel phosphorylation of troponin I.";
RL   Circ. Res. 91:509-516(2002).
RN   [8]
RP   PHOSPHORYLATION AT SER-23 AND SER-24.
RX   PubMed=15514163; DOI=10.1161/01.res.0000149299.34793.3c;
RA   Haworth R.S., Cuello F., Herron T.J., Franzen G., Kentish J.C., Gautel M.,
RA   Avkiran M.;
RT   "Protein kinase D is a novel mediator of cardiac troponin I phosphorylation
RT   and regulates myofilament function.";
RL   Circ. Res. 95:1091-1099(2004).
RN   [9]
RP   INTERACTION WITH TRIM63.
RX   PubMed=15601779; DOI=10.1073/pnas.0404341102;
RA   Kedar V., McDonough H., Arya R., Li H.-H., Rockman H.A., Patterson C.;
RT   "Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that
RT   degrades cardiac troponin I.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:18135-18140(2004).
RN   [10]
RP   INTERACTION WITH STK4/MST1, AND PHOSPHORYLATION AT THR-31; THR-51; THR-129
RP   AND THR-143.
RX   PubMed=18986304; DOI=10.1042/bj20081340;
RA   You B., Yan G., Zhang Z., Yan L., Li J., Ge Q., Jin J.P., Sun J.;
RT   "Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase
RT   1.";
RL   Biochem. J. 418:93-101(2009).
RN   [11]
RP   PHOSPHORYLATION AT SER-5; SER-6; SER-23; SER-24; TYR-26; SER-42; SER-44;
RP   THR-51; SER-77; THR-78; THR-143; SER-166; THR-181 AND SER-199.
RX   PubMed=22972900; DOI=10.1161/circulationaha.112.096388;
RA   Zhang P., Kirk J.A., Ji W., dos Remedios C.G., Kass D.A., Van Eyk J.E.,
RA   Murphy A.M.;
RT   "Multiple reaction monitoring to identify site-specific troponin I
RT   phosphorylated residues in the failing human heart.";
RL   Circulation 126:1828-1837(2012).
RN   [12]
RP   STRUCTURE BY NMR OF 148-164.
RX   PubMed=10387074; DOI=10.1021/bi9901679;
RA   Li M.X., Spyracopoulos L., Sykes B.D.;
RT   "Binding of cardiac troponin-I147-163 induces a structural opening in human
RT   cardiac troponin-C.";
RL   Biochemistry 38:8289-8298(1999).
RN   [13]
RP   STRUCTURE BY NMR OF 149-165 IN COMPLEX WITH CARDIAC TROPONIN C.
RX   PubMed=12060657; DOI=10.1074/jbc.m203896200;
RA   Wang X., Li M.X., Sykes B.D.;
RT   "Structure of the regulatory N-domain of human cardiac troponin C in
RT   complex with human cardiac troponin I147-163 and bepridil.";
RL   J. Biol. Chem. 277:31124-31133(2002).
RN   [14]
RP   VARIANTS CMH7 GLY-145 AND GLN-206.
RX   PubMed=9241277; DOI=10.1038/ng0897-379;
RA   Kimura A., Harada H., Park J.-E., Nishi H., Satoh M., Takahashi M.,
RA   Hiroi S., Sasaoka T., Ohbuchi N., Nakamura T., Koyanagi T., Hwang T.-H.,
RA   Choo J., Chung K.-S., Hasegawa A., Nagai R., Okazaki O., Nakamura H.,
RA   Matsuzaki M., Sakamoto T., Toshima H., Koga Y., Imaizumi T., Sasazuki T.;
RT   "Mutations in the cardiac troponin I gene associated with hypertrophic
RT   cardiomyopathy.";
RL   Nat. Genet. 16:379-382(1997).
RN   [15]
RP   VARIANT CMH7 ASN-196, AND VARIANT SER-82.
RX   PubMed=11815426; DOI=10.1161/hc0402.102990;
RA   Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G.,
RA   Seidman C.E.;
RT   "Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the
RT   elderly.";
RL   Circulation 105:446-451(2002).
RN   [16]
RP   VARIANTS RCM1 GLN-144; TRP-145; THR-171; GLU-178; HIS-190 AND HIS-192.
RX   PubMed=12531876; DOI=10.1172/jci200316336;
RA   Mogensen J., Kubo T., Duque M., Uribe W., Shaw A., Murphy R., Gimeno J.R.,
RA   Elliott P., McKenna W.J.;
RT   "Idiopathic restrictive cardiomyopathy is part of the clinical expression
RT   of cardiac troponin I mutations.";
RL   J. Clin. Invest. 111:209-216(2003).
RN   [17]
RP   VARIANTS CMH7 GLN-141; VAL-157; PRO-162; LYS-177 DEL; GLN-186 AND ASN-196.
RX   PubMed=12707239; DOI=10.1161/01.cir.0000066323.15244.54;
RA   Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C.,
RA   Benaiche A., Isnard R., Dubourg O., Burban M., Gueffet J.-P., Millaire A.,
RA   Desnos M., Schwartz K., Hainque B., Komajda M.;
RT   "Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of
RT   mutations, and implications for a molecular diagnosis strategy.";
RL   Circulation 107:2227-2232(2003).
RN   [18]
RP   ERRATUM OF PUBMED:12707239.
RA   Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C.,
RA   Benaiche A., Isnard R., Dubourg O., Burban M., Gueffet J.-P., Millaire A.,
RA   Desnos M., Schwartz K., Hainque B., Komajda M.;
RL   Circulation 109:3258-3258(2004).
RN   [19]
RP   VARIANT CMH7 PHE-166.
RX   PubMed=12974739; DOI=10.1034/j.1399-0004.2003.00151.x;
RA   Erdmann J., Daehmlow S., Wischke S., Senyuva M., Werner U., Raible J.,
RA   Tanis N., Dyachenko S., Hummel M., Hetzer R., Regitz-Zagrosek V.;
RT   "Mutation spectrum in a large cohort of unrelated consecutive patients with
RT   hypertrophic cardiomyopathy.";
RL   Clin. Genet. 64:339-349(2003).
RN   [20]
RP   VARIANT CMD2A VAL-2.
RX   PubMed=15070570; DOI=10.1016/s0140-6736(04)15468-8;
RA   Murphy R.T., Mogensen J., Shaw A., Kubo T., Hughes S., McKenna W.J.;
RT   "Novel mutation in cardiac troponin I in recessive idiopathic dilated
RT   cardiomyopathy.";
RL   Lancet 363:371-372(2004).
RN   [21]
RP   VARIANTS CMH7 PRO-162; GLN-162 AND HIS-204.
RX   PubMed=16199542; DOI=10.1136/jmg.2005.033886;
RA   Ingles J., Doolan A., Chiu C., Seidman J., Seidman C., Semsarian C.;
RT   "Compound and double mutations in patients with hypertrophic
RT   cardiomyopathy: implications for genetic testing and counselling.";
RL   J. Med. Genet. 42:E59-E59(2005).
RN   [22]
RP   VARIANTS CMD1FF GLN-36 AND LYS-185.
RX   PubMed=19590045; DOI=10.1161/circresaha.109.196055;
RA   Carballo S., Robinson P., Otway R., Fatkin D., Jongbloed J.D., de Jonge N.,
RA   Blair E., van Tintelen J.P., Redwood C., Watkins H.;
RT   "Identification and functional characterization of cardiac troponin I as a
RT   novel disease gene in autosomal dominant dilated cardiomyopathy.";
RL   Circ. Res. 105:375-382(2009).
RN   [23]
RP   VARIANT CMD1FF GLY-116.
RX   PubMed=21846512; DOI=10.1016/j.ejmg.2011.07.005;
RA   Millat G., Bouvagnet P., Chevalier P., Sebbag L., Dulac A., Dauphin C.,
RA   Jouk P.S., Delrue M.A., Thambo J.B., Le Metayer P., Seronde M.F.,
RA   Faivre L., Eicher J.C., Rousson R.;
RT   "Clinical and mutational spectrum in a cohort of 105 unrelated patients
RT   with dilated cardiomyopathy.";
RL   Eur. J. Med. Genet. 54:E570-E575(2011).
CC   -!- FUNCTION: Troponin I is the inhibitory subunit of troponin, the thin
CC       filament regulatory complex which confers calcium-sensitivity to
CC       striated muscle actomyosin ATPase activity.
CC   -!- SUBUNIT: Binds to actin and tropomyosin. Interacts with TRIM63.
CC       Interacts with STK4/MST1. {ECO:0000269|PubMed:12060657,
CC       ECO:0000269|PubMed:15601779, ECO:0000269|PubMed:18986304}.
CC   -!- INTERACTION:
CC       P19429; Q5VU43-11: PDE4DIP; NbExp=4; IntAct=EBI-704146, EBI-10769071;
CC       P19429; O43933: PEX1; NbExp=3; IntAct=EBI-704146, EBI-988601;
CC       P19429; A6NK89: RASSF10; NbExp=3; IntAct=EBI-704146, EBI-6912267;
CC       P19429; Q9UKA8-1: RCAN3; NbExp=3; IntAct=EBI-704146, EBI-10762111;
CC       P19429; Q9UKA8-4: RCAN3; NbExp=2; IntAct=EBI-704146, EBI-10762136;
CC       P19429; P02585: TNNC2; NbExp=3; IntAct=EBI-704146, EBI-10249681;
CC       P19429; Q59H18: TNNI3K; NbExp=2; IntAct=EBI-704146, EBI-704142;
CC       P19429; Q59H18-2: TNNI3K; NbExp=2; IntAct=EBI-704146, EBI-10762055;
CC       P19429; O76024: WFS1; NbExp=3; IntAct=EBI-704146, EBI-720609;
CC   -!- PTM: Phosphorylated at Ser-42 and Ser-44 by PRKCE; phosphorylation
CC       increases myocardium contractile dysfunction (By similarity).
CC       Phosphorylated at Ser-23 and Ser-24 by PRKD1; phosphorylation reduces
CC       myofilament calcium sensitivity. Phosphorylated preferentially at Thr-
CC       31. Phosphorylation by STK4/MST1 alters its binding affinity to TNNC1
CC       (cardiac Tn-C) and TNNT2 (cardiac Tn-T). {ECO:0000250,
CC       ECO:0000269|PubMed:12242269, ECO:0000269|PubMed:15514163,
CC       ECO:0000269|PubMed:18986304, ECO:0000269|PubMed:2226863,
CC       ECO:0000269|PubMed:22972900, ECO:0000269|PubMed:9346285}.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]: A
CC       hereditary heart disorder characterized by ventricular hypertrophy,
CC       which is usually asymmetric and often involves the interventricular
CC       septum. The symptoms include dyspnea, syncope, collapse, palpitations,
CC       and chest pain. They can be readily provoked by exercise. The disorder
CC       has inter- and intrafamilial variability ranging from benign to
CC       malignant forms with high risk of cardiac failure and sudden cardiac
CC       death. {ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:12707239,
CC       ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:16199542,
CC       ECO:0000269|PubMed:9241277}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210]: A
CC       heart disorder characterized by impaired filling of the ventricles with
CC       reduced diastolic volume, in the presence of normal or near normal wall
CC       thickness and systolic function. {ECO:0000269|PubMed:12531876}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 2A (CMD2A) [MIM:611880]: A disorder
CC       characterized by ventricular dilation and impaired systolic function,
CC       resulting in congestive heart failure and arrhythmia. Patients are at
CC       risk of premature death. {ECO:0000269|PubMed:15070570}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1FF (CMD1FF) [MIM:613286]: A disorder
CC       characterized by ventricular dilation and impaired systolic function,
CC       resulting in congestive heart failure and arrhythmia. Patients are at
CC       risk of premature death. {ECO:0000269|PubMed:19590045,
CC       ECO:0000269|PubMed:21846512}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the troponin I family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X54163; CAA38102.1; -; mRNA.
DR   EMBL; M64247; AAA16157.1; -; mRNA.
DR   EMBL; X90780; CAA62301.1; -; Genomic_DNA.
DR   CCDS; CCDS42628.1; -.
DR   PIR; A61229; TPHUIC.
DR   RefSeq; NP_000354.4; NM_000363.4.
DR   PDB; 1J1D; X-ray; 2.61 A; C/F=31-163.
DR   PDB; 1J1E; X-ray; 3.30 A; C/F=31-210.
DR   PDB; 1LXF; NMR; -; I=148-164.
DR   PDB; 1MXL; NMR; -; I=148-164.
DR   PDB; 1OZS; NMR; -; B=129-148.
DR   PDB; 2KGB; NMR; -; I=145-164.
DR   PDB; 2KRD; NMR; -; I=148-164.
DR   PDB; 2L1R; NMR; -; B=145-164.
DR   PDB; 2MZP; NMR; -; I=145-171.
DR   PDB; 2N7L; NMR; -; C=145-174.
DR   PDB; 4Y99; X-ray; 2.00 A; C=1-210.
DR   PDB; 5VLN; NMR; -; A=139-164.
DR   PDB; 5W88; NMR; -; A=133-164.
DR   PDB; 5WCL; NMR; -; A=139-164.
DR   PDB; 6KN7; EM; 6.60 A; U/b=41-210.
DR   PDB; 6KN8; EM; 4.80 A; U/b=41-166.
DR   PDB; 6MV3; NMR; -; A=139-164.
DR   PDB; 7JGI; NMR; -; A=139-164.
DR   PDBsum; 1J1D; -.
DR   PDBsum; 1J1E; -.
DR   PDBsum; 1LXF; -.
DR   PDBsum; 1MXL; -.
DR   PDBsum; 1OZS; -.
DR   PDBsum; 2KGB; -.
DR   PDBsum; 2KRD; -.
DR   PDBsum; 2L1R; -.
DR   PDBsum; 2MZP; -.
DR   PDBsum; 2N7L; -.
DR   PDBsum; 4Y99; -.
DR   PDBsum; 5VLN; -.
DR   PDBsum; 5W88; -.
DR   PDBsum; 5WCL; -.
DR   PDBsum; 6KN7; -.
DR   PDBsum; 6KN8; -.
DR   PDBsum; 6MV3; -.
DR   PDBsum; 7JGI; -.
DR   BMRB; P19429; -.
DR   SMR; P19429; -.
DR   BioGRID; 112991; 18.
DR   ComplexPortal; CPX-3280; Cardiac Troponin complex.
DR   DIP; DIP-34065N; -.
DR   IntAct; P19429; 23.
DR   MINT; P19429; -.
DR   STRING; 9606.ENSP00000341838; -.
DR   ChEMBL; CHEMBL2095202; -.
DR   DrugBank; DB04513; N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide.
DR   iPTMnet; P19429; -.
DR   PhosphoSitePlus; P19429; -.
DR   BioMuta; TNNI3; -.
DR   DMDM; 136213; -.
DR   MassIVE; P19429; -.
DR   PaxDb; P19429; -.
DR   PeptideAtlas; P19429; -.
DR   PRIDE; P19429; -.
DR   ProteomicsDB; 53658; -.
DR   ABCD; P19429; 2 sequenced antibodies.
DR   Antibodypedia; 4354; 2516 antibodies.
DR   CPTC; P19429; 1 antibody.
DR   DNASU; 7137; -.
DR   Ensembl; ENST00000344887; ENSP00000341838; ENSG00000129991.
DR   GeneID; 7137; -.
DR   KEGG; hsa:7137; -.
DR   CTD; 7137; -.
DR   DisGeNET; 7137; -.
DR   GeneCards; TNNI3; -.
DR   GeneReviews; TNNI3; -.
DR   HGNC; HGNC:11947; TNNI3.
DR   HPA; ENSG00000129991; Tissue enriched (heart).
DR   MalaCards; TNNI3; -.
DR   MIM; 115210; phenotype.
DR   MIM; 191044; gene.
DR   MIM; 611880; phenotype.
DR   MIM; 613286; phenotype.
DR   MIM; 613690; phenotype.
DR   neXtProt; NX_P19429; -.
DR   OpenTargets; ENSG00000129991; -.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   Orphanet; 75249; Familial isolated restrictive cardiomyopathy.
DR   Orphanet; 155; NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.
DR   PharmGKB; PA36636; -.
DR   VEuPathDB; HostDB:ENSG00000129991.12; -.
DR   eggNOG; KOG3977; Eukaryota.
DR   GeneTree; ENSGT01000000214533; -.
DR   InParanoid; P19429; -.
DR   OMA; CKEIHQK; -.
DR   OrthoDB; 1566919at2759; -.
DR   PhylomeDB; P19429; -.
DR   TreeFam; TF313374; -.
DR   PathwayCommons; P19429; -.
DR   Reactome; R-HSA-390522; Striated Muscle Contraction.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   SIGNOR; P19429; -.
DR   BioGRID-ORCS; 7137; 14 hits in 992 CRISPR screens.
DR   ChiTaRS; TNNI3; human.
DR   EvolutionaryTrace; P19429; -.
DR   GeneWiki; TNNI3; -.
DR   GenomeRNAi; 7137; -.
DR   Pharos; P19429; Tbio.
DR   PRO; PR:P19429; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P19429; protein.
DR   Bgee; ENSG00000129991; Expressed in apex of heart and 127 other tissues.
DR   ExpressionAtlas; P19429; baseline and differential.
DR   Genevisible; P19429; HS.
DR   GO; GO:0097512; C:cardiac myofibril; IMP:CAFA.
DR   GO; GO:1990584; C:cardiac Troponin complex; IMP:CAFA.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030017; C:sarcomere; TAS:BHF-UCL.
DR   GO; GO:0005861; C:troponin complex; IDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IPI:CAFA.
DR   GO; GO:0019855; F:calcium channel inhibitor activity; IPI:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0030172; F:troponin C binding; IPI:UniProtKB.
DR   GO; GO:0031014; F:troponin T binding; IPI:UniProtKB.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0060047; P:heart contraction; IMP:UniProtKB.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; IBA:GO_Central.
DR   GO; GO:0030049; P:muscle filament sliding; TAS:Reactome.
DR   GO; GO:0032780; P:negative regulation of ATPase activity; IDA:UniProtKB.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IMP:CAFA.
DR   GO; GO:0001980; P:regulation of systemic arterial blood pressure by ischemic conditions; ISS:UniProtKB.
DR   GO; GO:0003009; P:skeletal muscle contraction; IBA:GO_Central.
DR   GO; GO:0001570; P:vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:HGNC-UCL.
DR   DisProt; DP00166; -.
DR   Gene3D; 1.20.5.350; -; 1.
DR   InterPro; IPR001978; Troponin.
DR   InterPro; IPR021666; Troponin-I_N.
DR   InterPro; IPR038077; Troponin_sf.
DR   Pfam; PF00992; Troponin; 1.
DR   Pfam; PF11636; Troponin-I_N; 1.
DR   SUPFAM; SSF90250; SSF90250; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Calcium; Cardiomyopathy;
KW   Direct protein sequencing; Disease variant; Metal-binding; Muscle protein;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2226863"
FT   CHAIN           2..210
FT                   /note="Troponin I, cardiac muscle"
FT                   /id="PRO_0000186151"
FT   CA_BIND         137..148
FT                   /evidence="ECO:0000250"
FT   REGION          32..79
FT                   /note="Involved in binding TNC"
FT   REGION          129..149
FT                   /note="Involved in binding TNC and actin"
FT   SITE            80
FT                   /note="Involved in TNI-TNT interactions"
FT   SITE            97
FT                   /note="Involved in TNI-TNT interactions"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:2226863"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   MOD_RES         23
FT                   /note="Phosphoserine; by PKA and PKD/PRKD1"
FT                   /evidence="ECO:0000269|PubMed:15514163,
FT                   ECO:0000269|PubMed:2226863, ECO:0000269|PubMed:22972900,
FT                   ECO:0000269|PubMed:9346285"
FT   MOD_RES         24
FT                   /note="Phosphoserine; by PKA and PKD/PRKD1"
FT                   /evidence="ECO:0000269|PubMed:15514163,
FT                   ECO:0000269|PubMed:2226863, ECO:0000269|PubMed:22972900,
FT                   ECO:0000269|PubMed:9346285"
FT   MOD_RES         26
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   MOD_RES         31
FT                   /note="Phosphothreonine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:18986304"
FT   MOD_RES         42
FT                   /note="Phosphoserine; by PKC/PRKCE"
FT                   /evidence="ECO:0000250|UniProtKB:P48787"
FT   MOD_RES         44
FT                   /note="Phosphoserine; by PKC/PRKCE"
FT                   /evidence="ECO:0000250|UniProtKB:P48787"
FT   MOD_RES         51
FT                   /note="Phosphothreonine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:18986304,
FT                   ECO:0000269|PubMed:22972900"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   MOD_RES         78
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   MOD_RES         129
FT                   /note="Phosphothreonine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:18986304"
FT   MOD_RES         143
FT                   /note="Phosphothreonine; by STK4/MST1"
FT                   /evidence="ECO:0000269|PubMed:18986304,
FT                   ECO:0000269|PubMed:22972900"
FT   MOD_RES         150
FT                   /note="Phosphoserine; by PAK3"
FT                   /evidence="ECO:0000269|PubMed:12242269"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   MOD_RES         181
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22972900"
FT   VARIANT         2
FT                   /note="A -> V (in CMD2A; dbSNP:rs397516359)"
FT                   /evidence="ECO:0000269|PubMed:15070570"
FT                   /id="VAR_043989"
FT   VARIANT         36
FT                   /note="K -> Q (in CMD1FF; dbSNP:rs267607130)"
FT                   /evidence="ECO:0000269|PubMed:19590045"
FT                   /id="VAR_063548"
FT   VARIANT         79
FT                   /note="R -> C (in dbSNP:rs3729712)"
FT                   /id="VAR_029453"
FT   VARIANT         82
FT                   /note="P -> S (risk factor for CMH7; dbSNP:rs77615401)"
FT                   /evidence="ECO:0000269|PubMed:11815426"
FT                   /id="VAR_016078"
FT   VARIANT         116
FT                   /note="A -> G (in CMD1FF; dbSNP:rs777177571)"
FT                   /evidence="ECO:0000269|PubMed:21846512"
FT                   /id="VAR_067264"
FT   VARIANT         141
FT                   /note="R -> Q (in CMH7; dbSNP:rs397516347)"
FT                   /evidence="ECO:0000269|PubMed:12707239"
FT                   /id="VAR_019872"
FT   VARIANT         144
FT                   /note="L -> Q (in RCM1; dbSNP:rs121917760)"
FT                   /evidence="ECO:0000269|PubMed:12531876"
FT                   /id="VAR_016079"
FT   VARIANT         145
FT                   /note="R -> G (in CMH7; dbSNP:rs104894724)"
FT                   /evidence="ECO:0000269|PubMed:9241277"
FT                   /id="VAR_007603"
FT   VARIANT         145
FT                   /note="R -> W (in RCM1; dbSNP:rs104894724)"
FT                   /evidence="ECO:0000269|PubMed:12531876"
FT                   /id="VAR_016080"
FT   VARIANT         157
FT                   /note="A -> V (in CMH7; dbSNP:rs397516353)"
FT                   /evidence="ECO:0000269|PubMed:12707239"
FT                   /id="VAR_019873"
FT   VARIANT         162
FT                   /note="R -> P (in CMH7; dbSNP:rs397516354)"
FT                   /evidence="ECO:0000269|PubMed:12707239,
FT                   ECO:0000269|PubMed:16199542"
FT                   /id="VAR_019874"
FT   VARIANT         162
FT                   /note="R -> Q (in CMH7; dbSNP:rs397516354)"
FT                   /evidence="ECO:0000269|PubMed:16199542"
FT                   /id="VAR_042745"
FT   VARIANT         166
FT                   /note="S -> F (in CMH7; dbSNP:rs727504242)"
FT                   /evidence="ECO:0000269|PubMed:12974739"
FT                   /id="VAR_029454"
FT   VARIANT         171
FT                   /note="A -> T (in RCM1; dbSNP:rs121917761)"
FT                   /evidence="ECO:0000269|PubMed:12531876"
FT                   /id="VAR_016081"
FT   VARIANT         177
FT                   /note="Missing (in CMH7)"
FT                   /evidence="ECO:0000269|PubMed:12707239"
FT                   /id="VAR_019875"
FT   VARIANT         178
FT                   /note="K -> E (in RCM1; dbSNP:rs104894730)"
FT                   /evidence="ECO:0000269|PubMed:12531876"
FT                   /id="VAR_016082"
FT   VARIANT         185
FT                   /note="N -> K (in CMD1FF; dbSNP:rs267607129)"
FT                   /evidence="ECO:0000269|PubMed:19590045"
FT                   /id="VAR_063549"
FT   VARIANT         186
FT                   /note="R -> Q (in CMH7; dbSNP:rs397516357)"
FT                   /evidence="ECO:0000269|PubMed:12707239"
FT                   /id="VAR_019876"
FT   VARIANT         190
FT                   /note="D -> H (in CMH7 and RCM1)"
FT                   /evidence="ECO:0000269|PubMed:12531876"
FT                   /id="VAR_016083"
FT   VARIANT         192
FT                   /note="R -> H (in RCM1; dbSNP:rs104894729)"
FT                   /evidence="ECO:0000269|PubMed:12531876"
FT                   /id="VAR_016084"
FT   VARIANT         196
FT                   /note="D -> N (in CMH7; dbSNP:rs104894727)"
FT                   /evidence="ECO:0000269|PubMed:11815426,
FT                   ECO:0000269|PubMed:12707239"
FT                   /id="VAR_016085"
FT   VARIANT         204
FT                   /note="R -> H (in CMH7; dbSNP:rs727504275)"
FT                   /evidence="ECO:0000269|PubMed:16199542"
FT                   /id="VAR_042746"
FT   VARIANT         206
FT                   /note="K -> Q (in CMH7; dbSNP:rs104894725)"
FT                   /evidence="ECO:0000269|PubMed:9241277"
FT                   /id="VAR_007604"
FT   HELIX           43..79
FT                   /evidence="ECO:0007744|PDB:4Y99"
FT   HELIX           85..87
FT                   /evidence="ECO:0007744|PDB:1J1E"
FT   HELIX           90..136
FT                   /evidence="ECO:0007744|PDB:4Y99"
FT   TURN            144..146
FT                   /evidence="ECO:0007744|PDB:5VLN"
FT   HELIX           151..159
FT                   /evidence="ECO:0007744|PDB:4Y99"
FT   HELIX           160..162
FT                   /evidence="ECO:0007744|PDB:4Y99"
FT   HELIX           163..188
FT                   /evidence="ECO:0007744|PDB:1J1E"
SQ   SEQUENCE   210 AA;  24008 MW;  20A804F8C24AE1B0 CRC64;
     MADGSSDAAR EPRPAPAPIR RRSSNYRAYA TEPHAKKKSK ISASRKLQLK TLLLQIAKQE
     LEREAEERRG EKGRALSTRC QPLELAGLGF AELQDLCRQL HARVDKVDEE RYDIEAKVTK
     NITEIADLTQ KIFDLRGKFK RPTLRRVRIS ADAMMQALLG ARAKESLDLR AHLKQVKKED
     TEKENREVGD WRKNIDALSG MEGRKKKFES
//
